Executives On The Move: Global Blood Therapeutics, Passage Bio and More
Recent executive changes in the industry include C-suite changes at Passage Bio and Neurelis. Meanwhile, new directors were appointed at Global Blood Therapeutics and Tarsus Pharmaceuticals.
You may also be interested in...
Recent executive moves in the industry include changes at the top at Spyre Therapeutics, Neopharmed Gentili and CytoDyn.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
In accepting Scrip’s Lifetime Achievement Award, Ovid Therapeutics’ CEO called on pharma to show responsible leadership and live up to its potential to do good for society.